COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04357730
Recruitment Status : Recruiting
First Posted : April 22, 2020
Last Update Posted : June 17, 2020
Genentech, Inc., University of Colorado Denver, National Jewish, Beth Israel Deaconess Medical Center, and Long Island Jewish Hospital
Information provided by (Responsible Party):
Ernest E. Moore, MD, Denver Health and Hospital Authority

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : November 2020